skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

A Long-Term Non-Interventional Registry to Assess Safety and Effectiveness of HUMIRA (Adalimumab) in Patients wtih Moderately to Severely Active Ulcerative Colitis (UC)

Location: Carle - Digestive Health Center
Body site or condition: Inflammatory Bowel Disease – Ulcerative Colitis
Department: Digestive Health

Carle 13069 LEGACY UC P11-282

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Apply Now